课题基金 / 基金详情

TARGETING HYALURONIDASES AS A STRATEGY TO REVERSE REMYELINATION FAILURE

TARGETING HYALURONIDASES AS A STRATEGY TO REVERSE REMYELINATION FAILURE
靶向透明质酸酶作为逆转髓鞘再生失败的策略
批准号:
8173316
负责人:
Larry S. Sherman
金额:
$5.71万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30

项目摘要

项目成果

Larry S. Sherman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The aims of this grant are to: Aim 1: Test the hypothesis that reducing the expression of specific hyaluronidases will promote OL progenitor maturation and remyelination in chemically-induced demyelinated lesions. Aim 2: Test if pharmacological inhibitors of hyaluronidase activity can promote remyelination in both chemically-induced demyelinated lesions and in lesions that occur in mice with EAE
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hyaluron as a regulator of chemotherapy-induced changes in neurogenesis
ROLE OF EXTRACELLULAR MATRIX IN HYPOXIC-ISCHEMIC PERINATAL WHITE MATTER INJURY
COLLABORATIVE MS RESEARCH CENTER AWARD
EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION
海外基金